A COVID vaccine study that had been previously blocked by the CDC was published recently in JAMA Network Open. The study in question sought to assess the effectiveness of the 2025-2026 COVID-19 vaccine against the said virus in adults without co-morbidities.
Testing a pool of about 85,000 participants, the study found that adults who received the vaccine were 50% less likely to be hospitalized for COVID and 55% less likely to go to the ER for COVID-related reasons than adults who did not. It echoed findings of previous studies, which also showed that taking the vaccine reduced the likelihood of hospitalization.
